[1]Chen B, Choi H, Hirsch LJ, et al. Cosmetic side effects ofantiepileptic drugs in adults with epilepsy. Epilepsy Behav, 2015, 42: 129-137
[2]Tomita T, Goto H, Yoshida T, et al. Dose-dependent valproate-induced alopecia in patients with mental disorders. Indian J Pharmacol, 2015, 47(6): 690-692
[3]刘伟, 蔡兴秋. 左乙拉西坦单药或添加治疗癫 的临床观察. 临床神经病学杂志, 2012, 25(3): 227-229
[4]Calabro RS, Bramanti P, Spina E, et al. Can zinc depletion play a role in LEV-induced hair loss? Considerations from a case study. Epilepsy Behav, 2013, 29(1): 254-255
[5]Zou X, Hong Z, Zhou D. Hair loss with levetiracetam in five patients with epilepsy. Seizure, 2014, 23(2): 158-160
[6]N. Oksuz HKHF. Abstracts. Epilepsia, 2018, 59: S278
[7]Hamd R, Hasbini D. Adolescent's Hair Loss due to Levetiracetam. Journal of Pediatric Epilepsy, 2018
[8]Watanabe S, Kuwabara Y, Suehiro S, et al. Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma. Eur J Clin Pharmacol, 2017, 73(3): 357-363
[9]Ramakrishnappa SK, Belhekar MN. Serum drug level-related sodium valproate-induced hair loss. Indian J Pharmacol, 2013, 45(2): 187-188
[10]Yilmaz Y, Tasdemir HA, Paksu MS. The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity. Eur J Paediatr Neurol, 2009, 13(5): 439-443
[11]Castro-Gago M, Perez-Gay L, Gomez-Lado C, et al. The influence of valproic acid and carbamazepine treatment on serum biotin and zinc levels and on biotinidase activity. J Child Neurol, 2011, 26(12): 1522-1524
[12]Rigo JM, Hans G, Nguyen L, et al. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA-and glycine-gated currents. Br J Pharmacol, 2002, 136(5): 659-672 |
